Holen Sie sich die Stockscreener-App
4.21
0.24%
-0.02
Schlusskurs vom Vortag:
$4.23
Offen:
$4.22
24-Stunden-Volumen:
8,264
Relative Volume:
0.06
Marktkapitalisierung:
$220.47M
Einnahmen:
$81.06M
Nettoeinkommen (Verlust:
$-55.55M
KGV:
-3.693
EPS:
-1.14
Netto-Cashflow:
$-47.98M
1W Leistung:
+0.72%
1M Leistung:
+20.92%
6M Leistung:
+69.48%
1J Leistung:
-37.57%
1-Tages-Spanne:
$4.0915
$4.23
1-Wochen-Bereich:
$4.02
$4.285
52-Wochen-Spanne:
$2.03
$7.05
Sight Sciences Inc Stock (SGHT) Company Profile
Firmenname
Sight Sciences Inc
Sektor
Branche
Telefon
(415) 889-0550
Adresse
4040 CAMPBELL AVE,, MENLO PARK
Vergleichen Sie SGHT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
4.21 | 219.42M | 81.06M | -55.55M | -47.98M | -1.14 |
|
ABT
Abbott Laboratories
|
131.79 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.87 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
390.62 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.03 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.67 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-08 | Hochstufung | Lake Street | Hold → Buy |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-11-04 | Herabstufung | Lake Street | Buy → Hold |
| 2024-08-21 | Eingeleitet | Lake Street | Buy |
| 2023-09-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-09-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-01-06 | Hochstufung | Stifel | Hold → Buy |
| 2022-10-04 | Eingeleitet | Needham | Hold |
| 2022-07-26 | Eingeleitet | Stifel | Hold |
| 2022-02-03 | Eingeleitet | William Blair | Outperform |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
Alle ansehen
Sight Sciences Inc Aktie (SGHT) Neueste Nachrichten
Visualizing Sight Sciences Inc. stock with heatmapsAnalyst Downgrade & Free Reliable Trade Execution Plans - Newser
Developing predictive dashboards with Sight Sciences Inc. dataStop Loss & Verified Stock Trade Ideas - Newser
How high can Sight Sciences Inc. stock goMarket Performance Summary & Capital Protection Trade Alerts - Newser
How to use a screener to detect Sight Sciences Inc. breakoutsJuly 2025 Macro Moves & Free Expert Verified Stock Movement Alerts - Newser
Can volume confirm reversal in Sight Sciences Inc.July 2025 Selloffs & Weekly High Return Stock Forecasts - Newser
What moving averages say about Sight Sciences Inc.Product Launch & Safe Entry Point Alerts - Newser
Can swing trading help recover from Sight Sciences Inc. lossesWeekly Profit Report & AI Powered Market Trend Analysis - Newser
Sight Sciences Inc. Reaches Critical Trendline SupportTrade Risk Summary & Fast Entry Momentum Trade Alerts - newsimpact.co.kr
Sight Sciences Inc. Stock Recovery Path — Analyst Breakdown2025 Performance Recap & Daily Technical Stock Forecast Reports - classian.co.kr
Compared to Estimates, Sight Sciences (SGHT) Q2 Earnings: A Look at Key Metrics - MSN
What machine learning models say about Sight Sciences Inc.Entry Point & Consistent Growth Equity Picks - Newser
Real time breakdown of Sight Sciences Inc. stock performanceJuly 2025 Trends & Stepwise Trade Signal Implementation - Newser
How Sight Sciences Inc. stock performs during market volatilityQuarterly Portfolio Summary & Smart Swing Trading Alerts - Newser
Should I buy Sight Sciences Inc. stock before earnings2025 Performance Recap & AI Powered Buy and Sell Recommendations - Newser
Will Sight Sciences Inc. see short term momentumQuarterly Investment Review & Free Expert Approved Momentum Trade Ideas - Newser
Technical signs of recovery in Sight Sciences Inc.2025 Price Targets & Technical Pattern Based Buy Signals - Newser
Analyzing Sight Sciences Inc. with risk reward ratio chartsQuarterly Performance Summary & Accurate Trade Setup Notifications - Newser
Will Sight Sciences Inc. price bounce be sustainable2025 Volatility Report & Real-Time Market Trend Scan - Newser
Chart based exit strategy for Sight Sciences Inc.July 2025 Summary & Long-Term Growth Portfolio Plans - Newser
RSI Suggests Rebound May Be Near in Sight Sciences Inc.CPI Data & Momentum Based Trading Ideas - 선데이타임즈
Sight Sciences Inc. Approaches Support With Recovery in SightMarket Growth Report & AI Powered Market Trend Analysis - sundaytimes.kr
Sight Sciences’ Earnings Call: Balancing Growth and Challenges - TipRanks
Sight Sciences, Inc. (NASDAQ:SGHT) Q2 2025 Earnings Call Transcript - MSN
Sight Sciences, Inc. (NASDAQ:SGHT) Given Average Recommendation of “Hold” by Brokerages - Defense World
Is Sight Sciences Inc. Stock a Good Fit for Conservative InvestorsEntry Optimization Guide with Volume Analysis - Newser
Sight Sciences, Inc. (NASDAQ:SGHT) Just Reported And Analysts Have Been Lifting Their Price Targets - 富途牛牛
Sight Sciences (SGHT) Stock Upgraded to 'Buy' with Raised Price Target by Lake Street - AInvest
Sight Sciences (NASDAQ:SGHT) Upgraded at Lake Street Capital - Defense World
Sight Sciences Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Sight Sciences (NASDAQ:SGHT) Raised to Hold at Wall Street Zen - Defense World
Will earnings trigger a reversal in Sight Sciences Inc.Free Conservative Long Term Growth Plans - Newser
Risk adjusted return profile for Sight Sciences Inc. analyzedPrice Action Trading with Volume Confirmation - Newser
Sector Leaders Rotate Capital Into Sight Sciences Inc.Community Shared Smart Money Signals Show Movement - metal.it
Sight Sciences raises 2025 revenue guidance to $72M–$76M amid strong OMNI growth and strategic focus on MIGS leadership - MSN
Does Sight Sciences (NASDAQ:SGHT) Have A Healthy Balance Sheet? - simplywall.st
A Quick Look at Today's Ratings for Sight Sciences(SGHT.US), With a Forecast Between $4 to $5 - 富途牛牛
QuinStreet: Lake Street lowers PT to $18 from $19, maintains Hold rating. - AInvest
Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates - NewsBreak: Local News & Alerts
Sight Sciences Reports Q2 EPS, Revenue Above Consensus, Glaucoma Ordering Accounts Reach New High - AInvest
Sight Sciences Raises FY25 Revenue Outlook to $72M-$76M, Reiterates Operating Expense Guidance of $101M-$105M. - AInvest
Sight Sciences stock rating upgraded by Lake Street on stabilizing business - Investing.com Nigeria
Finanzdaten der Sight Sciences Inc-Aktie (SGHT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sight Sciences Inc-Aktie (SGHT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| HAYDEN JEREMY B. | Chief Legal Officer |
Jul 03 '25 |
Sale |
4.17 |
9,160 |
38,234 |
266,321 |
| Bauerlein Alison | Chief Financial Officer |
Jul 02 '25 |
Sale |
4.10 |
19,260 |
78,927 |
617,468 |
| Badawi Paul | President and CEO |
Jul 01 '25 |
Sale |
4.15 |
23,637 |
98,141 |
5,986,943 |
| Badawi David | Chief Technology Officer |
Jul 03 '25 |
Sale |
4.17 |
5,679 |
23,704 |
1,831,025 |
| Link Matthew | Chief Commercial Officer |
Jul 02 '25 |
Sale |
4.10 |
4,889 |
20,035 |
832,293 |
0.09%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):